Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

ImmunoCellular Therapeutics Ltd.

TRADE

AMEX: IMUCHealthcare / Biotechnology / USA
0.2100.00Vol 143 8781Y Perf -36.76%
Aug 17th, 2018 16:00
BID0.00 ASK0.22
Open0.22 Previous Close0.21
Pre-Market0.22 After-Trading-
 0.01 4.76%  - -%
Target Price
5.00 
Analyst Rating
Hold 3.00
Potencial %
2 280.95 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)9 
Earnings Rating
Price Range Ratio 52wk %
34.62 
Earnings Date

Today's Price Range

0.210.22

 

52wk Range

0.030.55

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-16.00%
3 Months
-25.00%
6 Months
-12.50%
1 Year
-36.76%
3 Years
-54.55%
5 Years
-92.25%

Quotes

Name / TickerPriceChg.Chg.%
IMUC0.210.00000.00
AAPL217.584.26002.00
GOOG1 200.96-5.5300-0.46
MSFT107.58-0.0600-0.06
XOM78.260.26000.33
WFC58.860.20000.34
JNJ134.471.99001.50
FB173.80-0.9000-0.52
GE12.300.00000.00
JPM114.770.00000.00
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.40
Current Ratio 3.50
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -20.90
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.58
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -1.10
Cash Flow Per Share -0.51
Price to Tangible Book2.58
Book Value per Share0.09
Enterprise Value (in ths.)4 428
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-76.84
ROE last 12 Months -615.81
Return on Assets (5Y Avg) -179.42
ROA last 12 Months -163.09
Return on Capital (5Y Avg) -118.15
ROC last 12 Months -595.14
Return on invested Capital Q -24.64
Return on invested Capital Y-311.75
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2016-2.00-1.6020.00
Q02 2016-2.80-2.4014.29
Q01 2016-2.80-2.800.00
Q04 2015-1.60-2.40-50.00
Q03 2015-1.60-1.600.00
Q02 2015-0.03-0.030.00
Q01 2015-0.02-0.04-100.00
Q04 2014-0.05-0.0420.00
Earnings Per EndEstimateRevision %Trend
12/2016 QR-1.7626.67Positive
12/2016 FY-6.7011.84Positive
12/2017 FY-8.572.61Positive
----
Next Report Date13th Aug 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume143 878
Shares Outstanding (in ths.)41 940
Trades Count256
Dollar Volume30 718
Avg. Volume818 387
Avg. Weekly Volume168 656
Avg. Monthly Volume166 789
Avg. Quarterly Volume285 056

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

48%52%

Bearish Bullish

48%52%

Bearish Bullish

57%43%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News

x